Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackson Burton

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|January 4, 2020
Hippocampal Neuroimaging-Informed Clinical Trial Enrichment Tool for Amnestic Mild Cognitive Impairment Using Open DataDaniela J Conrado, Jackson Burton, Derek Hill, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 3, 2024
Type 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development toolJuan Francisco Morales, Marian Klose, Yannick Hoffert, et al.
Clinical Pharmacology and Therapeutics|January 20, 2020
Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open DataDaniela J Conrado, Sridhar Duvvuri, Hugo Geerts, et al.
Frontiers in Neurology|November 8, 2021
Recommendations to Optimize the Use of Volumetric MRI in Huntington's Disease Clinical TrialsKirsi M Kinnunen, Ariana P Mullin, Dorian Pustina, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 7, 2020
Machine Learning in Drug Discovery and Development Part 1: A PrimerAlan Talevi, Juan Francisco Morales, Gregory Hather, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 15, 2023
Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studiesJuan Francisco Morales, Rhoda Muse, Jagdeep T Podichetty, et al.
Clinical and Translational Science|February 2, 2019
Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's DiseaseKlaus Romero, Daniela Conrado, Jackson Burton, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 27, 2024
A computational tool to optimize clinical trial parameter selection in Duchenne muscular dystrophy: A practical guide and case studiesJordan Wilk, Varun Aggarwal, Mike Pauley, et al.
NPJ Digital Medicine|July 15, 2022
Identifying and characterising sources of variability in digital outcome measures in Parkinson's diseaseGeorge Roussos, Teresa Ruiz Herrero, Derek L Hill, et al.
Clinical Pharmacology and Therapeutics|September 24, 2019
Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsMalidi Ahamadi, Daniela J Conrado, Sreeraj Macha, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|January 4, 2020
Hippocampal Neuroimaging-Informed Clinical Trial Enrichment Tool for Amnestic Mild Cognitive Impairment Using Open DataDaniela J Conrado, Jackson Burton, Derek Hill, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 3, 2024
Type 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development toolJuan Francisco Morales, Marian Klose, Yannick Hoffert, et al.
Clinical Pharmacology and Therapeutics|January 20, 2020
Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open DataDaniela J Conrado, Sridhar Duvvuri, Hugo Geerts, et al.
Frontiers in Neurology|November 8, 2021
Recommendations to Optimize the Use of Volumetric MRI in Huntington's Disease Clinical TrialsKirsi M Kinnunen, Ariana P Mullin, Dorian Pustina, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 7, 2020
Machine Learning in Drug Discovery and Development Part 1: A PrimerAlan Talevi, Juan Francisco Morales, Gregory Hather, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 15, 2023
Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studiesJuan Francisco Morales, Rhoda Muse, Jagdeep T Podichetty, et al.
Clinical and Translational Science|February 2, 2019
Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's DiseaseKlaus Romero, Daniela Conrado, Jackson Burton, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 27, 2024
A computational tool to optimize clinical trial parameter selection in Duchenne muscular dystrophy: A practical guide and case studiesJordan Wilk, Varun Aggarwal, Mike Pauley, et al.
NPJ Digital Medicine|July 15, 2022
Identifying and characterising sources of variability in digital outcome measures in Parkinson's diseaseGeorge Roussos, Teresa Ruiz Herrero, Derek L Hill, et al.
Clinical Pharmacology and Therapeutics|September 24, 2019
Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsMalidi Ahamadi, Daniela J Conrado, Sreeraj Macha, et al.
Pageof 3